J. Randolph Hecht MD
Gastrointestinal Cancer
Professor of Clinical Medicine; Director UCLA GI Oncology Program
Join to View Full Profile
200 Medical 420 530 120 Plz# 365Los Angeles, CA 90095
Phone+1 310-586-2097
Fax+1 310-586-0841
Dr. Hecht is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1997- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1988 - 1991
University of ChicagoFellowship, Research, 1987 - 1988
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1984 - 1987
Eastern Virginia Medical SchoolClass of 1984
Certifications & Licensure
CA State Medical License 1988 - 2025
IL State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors Start of enrollment: 2023 Nov 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma.Joel Randolph Hecht, Arjun Oberoi, Elena Garralda Cabanas, Hong Jae Chon, Antonia Digklia
The Oncologist. 2025-03-10 - 235 citationsErlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Cl...Malcolm J Moore, David Goldstein, John Hamm, Arie Figer, Joel R Hecht
Journal of Clinical Oncology. 2023-10-20 - 5 citationsFecal and Tissue Microbiota Are Associated with Tumor T-Cell Infiltration and Mesenteric Lymph Node Involvement in Colorectal Cancer.Kayti Luu, Jason Y Ye, Venu Lagishetty, Fengting Liang, Megan Hauer
Nutrients. 2023-01-09
Lectures
- A phase 1b/2, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into primary and metastatic liver tumors alone and in c...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Overall survival of PEGylated pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC).2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Professional Memberships
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
